Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Odoni

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Nephrology|February 25, 2000
Diabetic nephropathy--what have we learned in the last three decades?G Odoni, E Ritz
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|January 21, 2004
[Neoangiogenesis: from molecular biology to clinical medicine]G Odoni, K Amann, E Ritz
Contributions to Nephrology|July 13, 2000
Smoking as a risk factor for end-stage renal failure in patients with primary renal diseaseS R Orth, G Odoni, H Ogata, et al.
Journal of Hypertension|July 27, 1999
Lacidipine reduces high blood pressure and the target organ damage induced by high fructose diet in ratsA Cosenzi, E Bernobich, N Plazzotta, et al.
Journal of the American Society of Nephrology : JASN|April 24, 1999
The ET(A) receptor blocker LU 135252 prevents chronic transplant nephropathy in the "Fisher to Lewis" modelS R Orth, G Odoni, K Amann, et al.
Journal of Cardiovascular Pharmacology|March 9, 1999
Lacidipine prevents the hypertension and renal and cardiac changes induced by high-fructose diet in WKY ratsA Cosenzi, A Sacerdote, P Seculin, et al.
American Journal of Physiology. Renal Physiology|October 22, 2010
Sympathetic blockade prevents the decrease in cardiac VEGF expression and capillary supply in experimental renal failureK Amann, G Odoni, K Benz, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Nephrology|February 25, 2000
Diabetic nephropathy--what have we learned in the last three decades?G Odoni, E Ritz
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|January 21, 2004
[Neoangiogenesis: from molecular biology to clinical medicine]G Odoni, K Amann, E Ritz
Contributions to Nephrology|July 13, 2000
Smoking as a risk factor for end-stage renal failure in patients with primary renal diseaseS R Orth, G Odoni, H Ogata, et al.
Journal of Hypertension|July 27, 1999
Lacidipine reduces high blood pressure and the target organ damage induced by high fructose diet in ratsA Cosenzi, E Bernobich, N Plazzotta, et al.
Journal of the American Society of Nephrology : JASN|April 24, 1999
The ET(A) receptor blocker LU 135252 prevents chronic transplant nephropathy in the "Fisher to Lewis" modelS R Orth, G Odoni, K Amann, et al.
Journal of Cardiovascular Pharmacology|March 9, 1999
Lacidipine prevents the hypertension and renal and cardiac changes induced by high-fructose diet in WKY ratsA Cosenzi, A Sacerdote, P Seculin, et al.
American Journal of Physiology. Renal Physiology|October 22, 2010
Sympathetic blockade prevents the decrease in cardiac VEGF expression and capillary supply in experimental renal failureK Amann, G Odoni, K Benz, et al.
Pageof 1